Skip to the page

Data / Form D filings / Tractus Corp

Tractus Corp: Form D filings

Tractus Corp, a biotechnology company in Austin, TX, filed 2 Form D notices with the SEC in 2023. The latest, on December 13, 2023, reports $865,000 sold of a $1 million offering to 15 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1710 #1 ROCKMOOR AVENUE, Austin, TX, 78703
Phone
(512) 906-1117
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2003155

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 13, 2023New notice$1,000,000$865,000$135,00015Dec 15, 2022sec.gov
Dec 13, 2023New notice$1,000,000$177,500$822,5006Sep 28, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brad HummelExecutive Officer, Director
Leonard DavenportDirector
August PetersonDirector
Robert Campbell IIIDirector

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Dec 11, 2023 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Tractus Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.